10.26 USD
▲-0.26+4.48%
盘后 9.83 +0.10%
2026-08-03
市值
$737.37M
市盈率
79.28
EPS
0.01
股息率
—
52 周区间
9.62 – 21.34
成交量
10.50K
Beta
0.09
目标价
34.35
52W 低 9.6252W 高 21.34
价格走势
公司简介
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also dev...